Literature DB >> 22849391

A creative approach to the development of an agenda for knowledge utilization: outputs from the 11th international knowledge utilization colloquium (KU 11).

Joyce E Wilkinson1, Jo Rycroft-Malone, Huw T O Davies, Brendan McCormack.   

Abstract

A group of researchers and practitioners interested in advancing knowledge utilization met as a colloquium in Belfast (KU 11) and used a "world café" approach to exploit the social capital and shared understanding built up over previous events to consider the research and practice agenda. We considered three key areas of relevance to knowledge use: (1) understanding the nature of research use, influence and impact; (2) blended and collaborative approaches to knowledge production and use; and (3) supporting sustainability and spread of evidence-informed innovations. The approach enabled the development of artifacts that reflected the three areas and these were analyzed using a creative hermeneutic approach. The themes that emerged and which are outlined in this commentary are not mutually exclusive. There was much overlap in the discussions and therefore of the themes, reflecting the complex nature of knowledge translation work. The agenda that has emerged from KU 11 also reflects the participatory and creative approach in which the meeting was structured and focused, and therefore emphasizes the processual, relational and contingent nature of some of the challenges we face. The past 20 years has seen an explosion in activity around understanding KU, and we have learned much about the difficulties. Whilst the agenda for the next decade may be becoming clearer, colloquia such as KU 11, using creative and engaging approaches, have a key role to play in dissecting, articulating and sharing that agenda. In this way, we also build an ever-expanding international community that is dedicated to working towards increasing the chances of success for better patient care.
© 2012 Sigma Theta Tau International.

Entities:  

Mesh:

Year:  2012        PMID: 22849391     DOI: 10.1111/j.1741-6787.2012.00261.x

Source DB:  PubMed          Journal:  Worldviews Evid Based Nurs        ISSN: 1545-102X            Impact factor:   2.931


  5 in total

1.  Patient and public engagement in health-related quality of life and patient-reported outcomes research: what is important and why should we care? Findings from the first ISOQOL patient engagement symposium.

Authors:  Kirstie Haywood; Jo Brett; Sam Salek; Nancy Marlett; Colin Penman; Svetlana Shklarov; Colleen Norris; Maria Jose Santana; Sophie Staniszewska
Journal:  Qual Life Res       Date:  2014-09-07       Impact factor: 4.147

2.  SCOPEOUT: sustainability and spread of quality improvement activities in long-term care- a mixed methods approach.

Authors:  Lisa A Cranley; Matthias Hoben; Jasper Yeung; Carole A Estabrooks; Peter G Norton; Adrian Wagg
Journal:  BMC Health Serv Res       Date:  2018-03-12       Impact factor: 2.655

3.  An organizational perspective on the long-term sustainability of a nursing best practice guidelines program: a case study.

Authors:  Andrea R Fleiszer; Sonia E Semenic; Judith A Ritchie; Marie-Claire Richer; Jean-Louis Denis
Journal:  BMC Health Serv Res       Date:  2015-12-03       Impact factor: 2.655

4.  Establishing the values for patient engagement (PE) in health-related quality of life (HRQoL) research: an international, multiple-stakeholder perspective.

Authors:  Kirstie Haywood; Anne Lyddiatt; Samantha J Brace-McDonnell; Sophie Staniszewska; Sam Salek
Journal:  Qual Life Res       Date:  2016-12-08       Impact factor: 4.147

5.  Reaching consensus on reporting patient and public involvement (PPI) in research: methods and lessons learned from the development of reporting guidelines.

Authors:  Jo Brett; Sophie Staniszewska; Iveta Simera; Kate Seers; Carole Mockford; Susan Goodlad; Doug Altman; David Moher; Rosemary Barber; Simon Denegri; Andrew Robert Entwistle; Peter Littlejohns; Christopher Morris; Rashida Suleman; Victoria Thomas; Colin Tysall
Journal:  BMJ Open       Date:  2017-10-22       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.